Want to join the conversation?
Biopharma company $REGN and Sanofi said placebo-controlled Phase 3 studies, LIBERTY AD SOLO 1 and SOLO 2, testing dupilumab in adults with moderate-to-severe atopic dermatitis met their main endpoints. Treatment with dupilumab as monotherapy were found to improve overall disease severity, skin clearing, itching, quality of life and mental health.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.